Point-of-Care Warfarin Monitoring in the ROCKET AF Trial.
作者信息
Powell J Robert
出版信息
N Engl J Med. 2016 Jul 28;375(4):390. doi: 10.1056/NEJMc1604020.
PMID:27433845
Abstract
摘要
相似文献
1
Point-of-Care Warfarin Monitoring in the ROCKET AF Trial.ROCKET AF试验中的即时华法林监测
N Engl J Med. 2016 Jul 28;375(4):390. doi: 10.1056/NEJMc1604020.
2
Point-of-Care Warfarin Monitoring in the ROCKET AF Trial.ROCKET AF试验中的即时华法林监测
N Engl J Med. 2016 Feb 25;374(8):785-8. doi: 10.1056/NEJMc1515842. Epub 2016 Feb 3.
3
Point-of-Care Warfarin Monitoring in the ROCKET AF Trial.ROCKET AF试验中的即时华法林监测
N Engl J Med. 2016 Jul 28;375(4):390-1. doi: 10.1056/NEJMc1604020. Epub 2016 Jul 6.
4
Stroke prevention in non-valvular atrial fibrillation with rivaroxaban.利伐沙班用于非瓣膜性心房颤动的卒中预防
Cardiovasc J Afr. 2014 Jul-Aug;25(4):196.
5
[The ROCKET AF study].[ROCKET AF研究]
G Ital Cardiol (Rome). 2012 Sep;13(9):553-6. doi: 10.1714/1133.12482.
6
Rivaroxaban for stroke prevention in atrial fibrillation: a critical review of the ROCKET AF trial.利伐沙班用于心房颤动的卒中预防：ROCKET AF试验的批判性综述
Expert Rev Cardiovasc Ther. 2012 Aug;10(8):965-72. doi: 10.1586/erc.12.91.
7
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.利伐沙班与华法林用于非瓣膜性心房颤动的比较
N Engl J Med. 2011 Dec 15;365(24):2334; author reply 2335. doi: 10.1056/NEJMc1112233.
8
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.利伐沙班与华法林用于非瓣膜性心房颤动的比较
N Engl J Med. 2011 Dec 15;365(24):2334-5; author reply 2335. doi: 10.1056/NEJMc1112233.
9
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.利伐沙班与华法林用于非瓣膜性心房颤动的比较
N Engl J Med. 2011 Dec 15;365(24):2333-4; author reply 2335. doi: 10.1056/NEJMc1112233.
10
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.利伐沙班与华法林用于非瓣膜性心房颤动的比较
N Engl J Med. 2011 Dec 15;365(24):2333; author reply 2335. doi: 10.1056/NEJMc1112233.
引用本文的文献
1
Navigating the choice of oral anticoagulation therapy for atrial fibrillation in the NOAC era.在新型口服抗凝药（NOAC）时代，为心房颤动患者选择口服抗凝治疗方案
Ther Adv Chronic Dis. 2017 Dec;8(12):165-176. doi: 10.1177/2040622317720106. Epub 2017 Jul 26.
Zotero 插件